Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range - Wikidata - wikimedia - TriplyDB

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

http://www.wikidata.org/entity/Q34329994

about

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression Altering the tropism of lentiviral vectors through pseudotyping.Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection In-vivo RGB marking and multicolour single-cell tracking in the adult brain A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.Molecular engineering of viral gene delivery vehicles Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells.Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV Retrovirus restriction by TRIM5alpha variants from Old World and New World primates Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra.Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex.Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation.Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.Lentiviral gene transfer into the dorsal root ganglion of adult rats.Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.Reverse Genetics Approaches to Control Arenavirus.Antisense gene silencing: therapy for neurodegenerative disorders?Retroviral vectors for gene therapy.RGB marking facilitates multicolor clonal cell tracking.

P2860

Q21090483-BC28BAB2-3B8C-441C-A642-877D771431DB Q24307712-B03E8725-1958-4810-BB0D-C77FA7FF12FE Q24337293-AB961AFE-B92A-427D-968C-B8AA7741B957 Q24538987-699D04BE-8DBC-45D1-940D-C1028CF54FE8 Q24628715-C7A719BA-27F9-4DD8-80B6-6354CAB5E7B8 Q28267000-1CDFB240-81D6-4ADD-9445-28B895EA6911 Q28270111-D9A67CC7-906E-4A7F-89AF-50E671DD92F0 Q28749594-C06B758E-ADF9-45C1-BCC9-1F8C965A95D9 Q30610594-9A230013-2221-4F33-80C5-9FB385C382D1 Q33283418-881B9DD2-AB58-4AB5-A62B-D7465FF72C65 Q33353795-6CDDFF93-B445-4744-940E-DD0A1E7901F9 Q33484184-25B46F7E-D5BB-4E13-87AD-9762E15828E6 Q33595161-9AAC219B-DC25-4062-9C74-389FC74E328A Q33644321-A3F13306-BE01-499F-BB6F-79480070FCF9 Q33707501-E71E1A53-C01F-4E47-883D-81D0FD18EC5D Q33712953-B23DC9C0-9912-4612-A7F6-9D03CC0AFE1C Q33887743-AF65A84A-13FE-4690-A486-201CC5B48E34 Q34200828-D1493B5F-14C2-4F5A-B9A8-551D3D606019 Q34334341-144DD95C-05ED-44BF-B007-33C7B9C0D05C Q34395707-F67F5DC3-62BA-4763-8E4A-EB630C79A16E Q34572037-0EA50E9F-A108-44EC-9BF3-CC58D966B0DD Q34684480-54AE6C90-4713-4647-8F21-4F3A372EE345 Q34719449-67D0409B-E17E-491C-A72B-4DC3EFB7096E Q35140332-82AA127C-358B-490D-A0CD-8C1AEE7604A3 Q35147223-3F5381C9-6808-44DF-ABA0-0B648E471F54 Q35231284-684A2231-9F93-4138-9150-87234FD39262 Q35543014-008B840A-A320-4910-BE38-B4F96377068A Q35543170-5089C733-3D97-4989-9D8D-08912DD287EB Q35848097-2555BFE9-6B83-4141-83EE-6664D0AADD44 Q36060923-D3815598-0A8E-4755-8812-A606D852D288 Q36186475-5FC51EB1-3DDA-40D2-A7E3-2DD1C7363A52 Q36315430-3DEF66C5-FA22-47A6-B986-76C910C83C32 Q36371457-D4CF2DA1-D4DF-4EB3-B77F-194229F9E183 Q36434299-027A873F-7C1E-4F17-9BC9-27BAA5D73095 Q36558535-7915F32D-0F44-41EB-8392-77289B2AF279 Q36760023-84C247D8-A2E9-4EE7-A91B-DF867910C385 Q37543755-06B4F1D3-F157-4155-A4AC-F4463DD99ADD Q37585001-825278FD-821D-4258-9B08-D6E383A14AA5 Q37809064-9A2DC27B-6EBE-4BE7-9B6E-22ECFDF1B4F5 Q38502837-73723623-EF68-4829-92FC-FA58A21150E7

P2860

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

http://www.wikidata.org/entity/Q34329994

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@ast

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@en

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@nl

type

label

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@ast

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@en

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@nl

prefLabel

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@ast

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@en

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@nl

P1433

Q34329994-E4828697-0E67-4579-B62E-4C3451BB485C

P1476

Q34329994-37403076-FED3-4B7F-BEB4-C5A197E9A209

P2093

Q34329994-25D44EAC-F135-49CD-9A99-5BC2DABC040A

Q34329994-70EDF52D-86C2-4CE4-A399-EC6931A94E9A

Q34329994-921D6A05-6726-4B69-8E38-11993AA0642E

P2860

Q34329994-0799F76E-32E4-4A77-A474-8E69614A5D3B

Q34329994-263C1146-A44A-42CC-8814-BC0343AD1297

Q34329994-2B41EB34-C46E-4C3D-BA8A-5097303228F5

Q34329994-34549081-444F-461D-A535-F87078C3A9E9

Q34329994-481C4CBC-2A6C-403C-800F-62B05E89F57B

Q34329994-56C06EEC-0B8F-4994-9366-372C3D100E67

Q34329994-5749959D-9AF6-4FF8-AB2A-4052EBCE64F7

Q34329994-5EE0969F-AF85-4F70-9510-529218788CCA

Q34329994-6A226E93-9128-453F-9752-47849F8E21CA

Q34329994-6D14EA62-E9AD-4025-ABC5-ECCA47778E3F

P304

Q34329994-B6BCAE08-8BA7-4A02-8D64-4996A7CF0B03

P31

Q34329994-1EA78C4A-D5EE-460C-93BC-82FF70CF6B86

P356

Q34329994-61D9789A-59D2-46F5-95D6-B97C3DEDD52E

P407

Q34329994-60D470DD-5769-4F4E-8121-5069C8847292

P433

Q34329994-7F4B90DB-E082-447C-A051-F80BFDAFD2D9

P478

Q34329994-0A3F4298-4306-4E1F-B6D4-806B730A0B0F

P50

Q34329994-EF30228E-49AE-4467-8091-61E04FD3FA37

P577

Q34329994-71EDC18A-2AEB-4FAF-B31D-7AE4F39A8F92

P5875

Q34329994-A313672A-5233-4739-87BF-8FAF7FB73BB6

P698

Q34329994-2B57E41C-7BE8-49C5-88AB-7D089E947226

P921

Q34329994-55E77943-0D1B-4003-8FD7-8DAD4BA29D3F

Q34329994-81DCE7A2-9610-4684-9984-FA5188503E79

P932

Q34329994-A329E3DC-5967-40CD-8EF6-932E9CF74D27

P356

JVI.76.3.1488-1495.2002

P1433

Journal of Virology

P1476

Oncoretrovirus and lentivirus ...... ntration, and broad host range

@en

P2093

Manfred Westphal

http://www.w3.org/2001/XMLSchema#string

Winfried R Beyer

http://www.w3.org/2001/XMLSchema#string

Wolfram Ostertag

http://www.w3.org/2001/XMLSchema#string

P2860

Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

Production of high-titer helper-free retroviruses by transient transfection

A third-generation lentivirus vector with a conditional packaging system

Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.

Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics.

Potential of gene therapy for brain tumors.

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

P304

1488-1495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.3.1488-1495.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Dorothee von Laer

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11585322

http://www.w3.org/2001/XMLSchema#string

P698

11773421

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

135847

http://www.w3.org/2001/XMLSchema#string